EUVIMEDEUVIMED entdecken
Editorial

What’s in a name? The costs and benefits of a formal autism diagnosis

Sue Fletcher-Watson iD

Autism · 2024-02 · 28 (2) · 257-262

DOI: 10.1177/13623613231213300 ↗

Kurz gefasst

Editorial in der Zeitschrift Autism, online erschienen am 24.11.2023. Verfasst von Sue Fletcher-Watson. Hauptthemen laut MEDLINE: Autistic Disorder, Autism Spectrum Disorder, Child Development Disorders, Pervasive. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autistic DisorderAutism Spectrum DisorderChild Development Disorders, PervasiveChildHumansCost-Benefit Analysis

Autor:innen und Institutionen

ORCID-Profile: Sue Fletcher-Watson

Zitieren

APA

Fletcher-Watson, S. (2024). What’s in a name? The costs and benefits of a formal autism diagnosis. Autism, 28(2), 257-262. https://doi.org/10.1177/13623613231213300

Vancouver

Fletcher-Watson S. What’s in a name? The costs and benefits of a formal autism diagnosis. Autism. 2024;28(2):257-262. doi:10.1177/13623613231213300

BibTeX
@article{FletcherWatson2024,
  author = {Fletcher-Watson, Sue},
  title = {What’s in a name? The costs and benefits of a formal autism diagnosis},
  journal = {Autism},
  year = {2024},
  volume = {28},
  number = {2},
  pages = {257--262},
  doi = {10.1177/13623613231213300}
}
Kostenlos starten →